228 related articles for article (PubMed ID: 30252138)
1. Quantitative profiling of cytokines and chemokines in DOCK8-deficient and atopic dermatitis patients.
Jacob M; Bin Khalaf D; Alhissi S; Arnout R; Alsaud B; Al-Mousa H; Lopata AL; Alazami AM; Dasouki M; Abdel Rahman AM
Allergy; 2019 Feb; 74(2):370-379. PubMed ID: 30252138
[TBL] [Abstract][Full Text] [Related]
2. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis.
Janssen E; Tsitsikov E; Al-Herz W; Lefranc G; Megarbane A; Dasouki M; Bonilla FA; Chatila T; Schneider L; Geha RS
Clin Immunol; 2014 Feb; 150(2):220-4. PubMed ID: 24440647
[TBL] [Abstract][Full Text] [Related]
4. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
5. Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis.
Jacob M; Masood A; Shinwari Z; Abdel Jabbar M; Al-Mousa H; Arnaout R; AlSaud B; Dasouki M; Alaiya AA; Abdel Rahman AM
Front Allergy; 2021; 2():774902. PubMed ID: 35386989
[TBL] [Abstract][Full Text] [Related]
6. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.
Engelhardt KR; Gertz ME; Keles S; Schäffer AA; Sigmund EC; Glocker C; Saghafi S; Pourpak Z; Ceja R; Sassi A; Graham LE; Massaad MJ; Mellouli F; Ben-Mustapha I; Khemiri M; Kilic SS; Etzioni A; Freeman AF; Thiel J; Schulze I; Al-Herz W; Metin A; Sanal Ö; Tezcan I; Yeganeh M; Niehues T; Dueckers G; Weinspach S; Patiroglu T; Unal E; Dasouki M; Yilmaz M; Genel F; Aytekin C; Kutukculer N; Somer A; Kilic M; Reisli I; Camcioglu Y; Gennery AR; Cant AJ; Jones A; Gaspar BH; Arkwright PD; Pietrogrande MC; Baz Z; Al-Tamemi S; Lougaris V; Lefranc G; Megarbane A; Boutros J; Galal N; Bejaoui M; Barbouche MR; Geha RS; Chatila TA; Grimbacher B
J Allergy Clin Immunol; 2015 Aug; 136(2):402-12. PubMed ID: 25724123
[TBL] [Abstract][Full Text] [Related]
7. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
[TBL] [Abstract][Full Text] [Related]
8. Dedicator of cytokinesis 8-deficient CD4
Tangye SG; Pillay B; Randall KL; Avery DT; Phan TG; Gray P; Ziegler JB; Smart JM; Peake J; Arkwright PD; Hambleton S; Orange J; Goodnow CC; Uzel G; Casanova JL; Lugo Reyes SO; Freeman AF; Su HC; Ma CS
J Allergy Clin Immunol; 2017 Mar; 139(3):933-949. PubMed ID: 27554822
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics Distinguishes DOCK8 Deficiency from Atopic Dermatitis: Towards a Biomarker Discovery.
Jacob M; Gu X; Luo X; Al-Mousa H; Arnaout R; Al-Saud B; L Lopata A; Li L; Dasouki M; Rahman AMA
Metabolites; 2019 Nov; 9(11):. PubMed ID: 31718082
[TBL] [Abstract][Full Text] [Related]
10. Human hyper-IgE syndrome: singular or plural?
Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations of DOCK8 deficiency syndrome.
Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
[TBL] [Abstract][Full Text] [Related]
12. DOCK8: regulator of Treg in response to corticotropin-releasing hormone.
Jin S; Shin JU; Noh JY; Kim H; Kim JY; Kim SH; Kim JH; Park CO; Lee N; Lee H; Lee JS; Lee KH
Allergy; 2016 Jun; 71(6):811-9. PubMed ID: 26799599
[TBL] [Abstract][Full Text] [Related]
13. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
[TBL] [Abstract][Full Text] [Related]
14. ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients.
Eken A; Cansever M; Okus FZ; Erdem S; Nain E; Azizoglu ZB; Haliloglu Y; Karakukcu M; Ozcan A; Devecioglu O; Aksu G; Arikan Ayyildiz Z; Topal E; Karakoc Aydiner E; Kiykim A; Metin A; Cipe F; Kaya A; Artac H; Reisli I; Guner SN; Uygun V; Karasu G; Dönmez Altuntas H; Canatan H; Oukka M; Ozen A; Chatila TA; Keles S; Baris S; Unal E; Patiroglu T
Allergy; 2020 Apr; 75(4):921-932. PubMed ID: 31596517
[TBL] [Abstract][Full Text] [Related]
15. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for DOCK8 deficiency-related severe dermatitis.
Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S
J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252
[TBL] [Abstract][Full Text] [Related]
17. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction.
Yamamura K; Uruno T; Shiraishi A; Tanaka Y; Ushijima M; Nakahara T; Watanabe M; Kido-Nakahara M; Tsuge I; Furue M; Fukui Y
Nat Commun; 2017 Jan; 8():13946. PubMed ID: 28067314
[TBL] [Abstract][Full Text] [Related]
19. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
20. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome.
Zhang Q; Davis JC; Dove CG; Su HC
Dis Markers; 2010; 29(3-4):131-9. PubMed ID: 21178272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
